Bioibérica is a spanish company that recycles animals wastes --for example: belly of pork, beef tracheas and rooster combs.
The Director of the company, Daniel Mediavilla, explain that debris can become products of interest.For example: from the mucous membrane of the stomach of a pig is got the Heparin (a substance necesary for the blood clotting).
Bioibérica also works with gorges of cow; from them they get the Condroitin sulfato (a substance that serves for regenerate the cartilage and treat diseases such as osteoarthritis.
From the rooter combs are obtained the "Ácido hialurónico" --this substance is also obtained from the skin of the shrimps--; this ácido serves as a filler in surgery and dentistry.In this sense, Bioibérica is a company that wants to be the first company in the treatment of the osteoarthitis; it has a special interest in regenerate cartilage and its func- tion anesthetic.
The ability to take advantage of waste does not end here. "The performance we get from these products is very low and less than 2%," says Verges (Medical Director and scientific of Bioibérica). "So we do studies, we collaborate with the university, hospitals or other centers of R & D to give added value," he says. From one of these works in cooperation with the academic world, particularly with the chair of the lawn at Virginia Tech, developed an amino acid can make the grass grow faster. With this product, now marketed under the name of Terra-Sorb, paid about 4.000 of the more than 16.000 golf courses in the U.S. there. Also market-oriented agriculture and as a way to get more from the production of heparin is the CeraTrap, a liquid that attracts flies and is used to control pests of fruit flies.
One of the key work is the approach Bioibérica between the centers of knowledge creation such as universities and other public research organizations, and private environment where this knowledge finds its application. "This collaboration has changed for the better," says Verges. "Before working with the company was considered sinful, but I think from the academic world can work with the company honestly, clearly stating the conflict of interest," he adds. From one of these collaborations, in particular through the Chair Bioibérica Tissue Engineering and Cell Therapy with the University of A Coruña have developed a saliva test to predict whether the patient will develop osteoarthritis more or less rapidly.
Despite the economic situation, Bioibérica, like many companies that support their business in science and technology, can not stand bad the crisis. Contrary to what happens in many other companies in Spain, has grown in number of employees: 352 in 2009 to 386 in 2011. The same has happened with the billing: from 212.68 million in 2010 to 243 in 2011. Its 12.5% investment in R & D (the Spanish average of 0.72%), 65% of university staff and 32% of export-based business are some facts that may be the key growth.
If you want to take more information, about this theme or another one, you can visit the website: www.esmateria.com
Sponsored by Costaluz Lawyers
(Click down here):